stars 1 stars 2 stars 3

MDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions. We offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. Through 2009 and 2010, MDS Inc. divested the assets of MDS Pharma Services: - The former discovery and preclinical businesses (Pharmacology/DMPK and Drug Safety Assessment) have been acquired by Ricerca Biosciences LLC. - The former early stage clinical research operations (the Development & Regulatory Services consultancy and Early Stage Development business) have been acquired by Celerion Inc. - The former late stage clinical research operations (Global Clinical Development) have been acquired by INC Research. - The former clinical laboratory operations (Global Clinical Development) have been acquired by Clearstone Central Laboratories..

MDS Pharma Services Questions

The MDS Pharma Services annual revenue was $198.5 million in 2026.

Sam Seever is the Vice President, Legal of MDS Pharma Services.

257 people are employed at MDS Pharma Services.

MDS Pharma Services is based in King of Prussia, Pennsylvania.

The NAICS codes for MDS Pharma Services are [54, 5417, 541].

The SIC codes for MDS Pharma Services are [87, 873].

Top MDS Pharma Services Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users